HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Andersen Syndrome

A form of inherited long QT syndrome (or LQT7) that is characterized by a triad of potassium-sensitive periodic paralysis, VENTRICULAR ECTOPIC BEATS, and abnormal features such as short stature, low-set ears, and SCOLIOSIS. It results from mutations of KCNJ2 gene which encodes a channel protein (INWARD RECTIFIER POTASSIUM CHANNELS) that regulates resting membrane potential.
Also Known As:
Long QT Syndrome 7; Syndrome, Andersen
Networked: 14 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1. Cardiac Arrhythmias (Arrythmia)
2. Brugada Syndrome
3. Paralysis (Palsy)
4. Long QT Syndrome
5. Jervell-Lange Nielsen Syndrome (Jervell and Lange-Nielsen Syndrome)

Experts

1. Priori, Silvia G: 2 articles (05/2004 - 10/2003)
2. Napolitano, Carlo: 2 articles (05/2004 - 10/2003)
3. Gómez, Ricardo: 1 article (08/2010)
4. Moraleda, Ignacio: 1 article (08/2010)
5. Sánchez-Chapula, José Antonio: 1 article (08/2010)
6. Dolz-Gaitón, Pablo: 1 article (08/2010)
7. Gálvez, Enrique: 1 article (08/2010)
8. Tamargo, Juan: 1 article (08/2010)
9. Amorós, Irene: 1 article (08/2010)
10. Duarte, Juan: 1 article (08/2010)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Andersen Syndrome:
1. Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA
2. PotassiumIBA
3. Andersen Tawil syndromeIBA
4. Polymorphic catecholergic ventricular tachycardiaIBA
5. Kir2.1 channelIBA
6. Potassium Channels (Potassium Channel)IBA
7. Ion Channels (Ion Channel)IBA
8. Flecainide (Tambocor)FDA LinkGeneric
9. Amiodarone (Amiodarona)FDA LinkGeneric
10. Acetazolamide (Diamox)FDA LinkGeneric